Branded or trademarked diets have similar levels of effectiveness; the key is sticking to it, a research study has found.
Sep 02, 2014
4.7 / 5 (3) | 0
(HealthDay)—For heavily pretreated, advanced ovarian cancer patients, an oral tablet inhibitor of poly ADP ribose polymerase, olaparib, can be safely administered with a weekly carboplatin/paclitaxel regimen, ...
Sep 11, 2014
not rated yet | 0